These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37085137)

  • 21. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mitochondria in nonalcoholic fatty liver disease.
    Nassir F; Ibdah JA
    Int J Mol Sci; 2014 May; 15(5):8713-42. PubMed ID: 24837835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‑alcoholic fatty liver disease.
    Maseko TE; Elkalaf M; Peterová E; Lotková H; Staňková P; Melek J; Dušek J; Žádníková P; Čížková D; Bezrouk A; Pávek P; Červinková Z; Kučera O
    Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38186319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD.
    Jin X; Yang YD; Chen K; Lv ZY; Zheng L; Liu YP; Chen SH; Yu CH; Jiang XY; Zhang CY; Li YM
    J Hepatol; 2009 May; 50(5):1019-28. PubMed ID: 19303656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.
    Grattagliano I; Montezinho LP; Oliveira PJ; Frühbeck G; Gómez-Ambrosi J; Montecucco F; Carbone F; Wieckowski MR; Wang DQ; Portincasa P
    Biochem Pharmacol; 2019 Feb; 160():34-45. PubMed ID: 30508523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine Protects against NEFA-Induced Impairment of Mitochondrial Respiratory Chain Function and Insulin Signaling in Bovine Hepatocytes.
    Shi Z; Li XB; Peng ZC; Fu SP; Zhao CX; Du XL; Fang ZY; Wang Z; Liu GW; Li XW
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
    PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice.
    Navarro CDC; Figueira TR; Francisco A; Dal'Bó GA; Ronchi JA; Rovani JC; Escanhoela CAF; Oliveira HCF; Castilho RF; Vercesi AE
    Free Radic Biol Med; 2017 Dec; 113():190-202. PubMed ID: 28964917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
    Galloway CA; Lee H; Brookes PS; Yoon Y
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G632-41. PubMed ID: 25080922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation.
    Diehl KL; Vorac J; Hofmann K; Meiser P; Unterweger I; Kuerschner L; Weighardt H; Förster I; Thiele C
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
    Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
    Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
    Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
    Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
    Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
    Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
    Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease.
    Ren T; Zhu L; Shen Y; Mou Q; Lin T; Feng H
    Food Funct; 2019 Mar; 10(3):1540-1551. PubMed ID: 30785444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
    Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.